Heart Transplant Market Report 2026

Heart Transplant Market Overview

• Heart Transplant market size has reached to $12.62 billion in 2025 • Expected to grow to $20.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Growth Of The Heart Transplant Market Fuels By Increasing Prevalence Of Cardiovascular Diseases • Market Trend: Innovations In Organ Preservation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Heart Transplant Market?

A heart transplant is a medical operation that involves removing and replacing a damaged or diseased heart with a healthy donor heart. It is a complex and life-saving medical intervention for individuals with end-stage heart failure or certain severe heart diseases. The main types of heart transplant surgeries are total artificial heart, biventricular pacing, ventricular assist devices, and others. A total artificial heart refers to a mechanical device designed to replace both the left and right ventricles of the natural human heart. It includes various transplants such as autograft, allograft, and others. The main end users are hospitals, cardiac institutes, and others.

What Is The Heart Transplant Market Growth Forecast?

The heart transplant market size is expected to see strong growth in the next few years. It will grow to $20.08 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing investments in artificial heart research, rising demand for long-term cardiac support solutions, expansion of donor management technologies, growing focus on precision post-transplant care, increasing adoption of digital health monitoring. Major trends in the forecast period include increasing adoption of ventricular assist devices, rising use of advanced transplant monitoring systems, growing integration of digital patient management platforms, expansion of artificial heart technologies, enhanced focus on post-transplant outcomes.

Global Heart Transplant Market Segmentation

1) By Transplant Procedure Type: Orthotopic Heart Transplant, Heterotopic Heart Transplant 2) By Donor Type: Allograft, Extended-Criteria Donor Hearts 3) By Indication: End-Stage Heart Failure, Ischemic Cardiomyopathy, Dilated Cardiomyopathy, Congenital Heart Disease, Valvular Heart Disease, Other Severe Cardiac Disorders 4) By Recipient Age Group: Pediatric Patients, Adult Patients, Geriatric Patients 5) By End User: Hospitals, Specialized Cardiac Transplant Centers, Academic & Research Institutes Subsegments: 1) By Orthotopic Heart Transplant: Standard Orthotopic Heart Transplant, Donation After Brain Death (DBD) Orthotopic Transplant, Donation After Circulatory Death (DCD) Orthotopic Transplant, ABO-Compatible Orthotopic Transplant 2) By Heterotopic Heart Transplant (HHT): Left Heterotopic Heart Transplant, Right Heterotopic Heart Transplant, Biventricular Heterotopic Heart Transplant, Bridge-to-Recovery Heterotopic Transplant

What Is The Driver Of The Heart Transplant Market?

The prevalence of cardiovascular diseases is expected to propel the growth of the heart transplant market going forward. Cardiovascular diseases are a range of conditions that affect the heart and blood arteries. A heart transplant is a last-resort treatment for people with end-stage heart failure who have not responded to other treatments. It improves quality of life and extends life expectancy. For instance, in September 2024, according to the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million individuals are currently affected by heart and circulatory diseases, comprising 4 million men and 3.6 million women. By 2030, this number could increase by 1 million, and by 2040, it may rise to 2 million more than the current figures. Therefore, the prevalence of cardiovascular diseases will drive the heart transplant industry.

Key Players In The Global Heart Transplant Market

Major companies operating in the heart transplant market are Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Johns Hopkins Hospital, NewYork-Presbyterian Hospital, Cedars-Sinai Medical Center, Stanford Health Care, Baylor St Lukes Medical Center, The Texas Heart Institute, Duke University Hospital, UCLA Medical Center, Mount Sinai Hospital, Brigham and Womens Hospital, University of Pittsburgh Medical Center, Houston Methodist Hospital, Northwestern Memorial Hospital, NYU Langone Health, Toronto General Hospital, Royal Papworth Hospital, Harefield Hospital

Global Heart Transplant Market Trends and Insights

Major companies operating in the heart transplant market are increasingly focused on developing innovative solutions, such as heart preservation technology, to improve patient outcomes and transplant success rates. It significantly extends the preservation time of the heart outside the body compared to traditional ice storage, allowing for improved outcomes and reduced complications post-transplantation. For instance, in May 2023, Xvivo Perfusion AB, a Sweden-based medical technology company, got approval from the U.S. Food and Drug Administration (FDA) for Investigational Device Exemption (IDE) application for its heart preservation technology, allowing the company to initiate the 'PRESERVE Clinical Trial.' This trial is a prospective, multicenter, single-arm, open-label study focused on evaluating hearts transplanted after non-ischemic heart preservation from extended donors, specifically including Donation after Circulatory Death (DCD) hearts. The main unique feature of XVIVO's heart preservation technology is its non-ischemic hypothermic perfusion system, which utilizes cold, oxygenated perfusion to preserve donor hearts during transport.

What Are Latest Mergers And Acquisitions In The Heart Transplant Market?

In August 2024, Getinge, a Sweden-based company specializing in medical technology and healthcare solutions acquired Paragonix Technologies for an undisclosed amount. Through this acquisition, Getinge aimed to enhance its capabilities in organ preservation and transportation, focusing on improving patient outcomes in transplant procedures. Paragonix Technologies is a US-based company that designs, manufactures, and sells organ transplant transport devices.

Regional Outlook

North America was the largest region in the heart transplant market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Heart Transplant Market?

The heart transplant market includes revenues earned by entities by providing services such as patient evaluation and selection, waitlist management, donor heart procurement, transplant surgery, immunosuppression management, psychosocial support and complications management services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Heart Transplant Market Report 2026?

The heart transplant market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the heart transplant industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.